Micafungin Versus Caspofungin For The Treatment Of Systemic Candida Infections- A Cost-Effectiveness Analysis For Switzerland
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1599
https://www.valueinhealthjournal.com/article/S1098-3015(14)01650-7/fulltext
Title :
Micafungin Versus Caspofungin For The Treatment Of Systemic Candida Infections- A Cost-Effectiveness Analysis For Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01650-7&doi=10.1016/j.jval.2014.03.1599
First page :
A275
Section Title :
Infection
Open access? :
No
Section Order :
1089